CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk

Relationship with polycystic ovary syndrome phenotypes

Francesca Moro, Andrea Morciano, Anna Tropea, Francesca Sagnella, Carola Palla, Elisa Scarinci, Nicola Cosentino, Giampaolo Niccoli, Giovanna Liuzzo, Filippo Crea, Antonio Lanzone, Rosanna Apa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To study the frequency of CD4+CD28null T cells, which are aggressive T lymphocytes associated with recurrent coronary instability and type 2 diabetes mellitus, in different polycystic ovary syndrome (PCOS) phenotypes and in age- and body mass index-matched healthy women. Design: Retrospective cohort observational study. Setting: Unit of human reproductive pathophysiology, university hospital. Patient(s): A total of 167 PCOS patients and 102 control subjects. Intervention(s): None. Main Outcome Measure(s): CD4+CD28null T cell frequency, high-sensitive C-reactive protein levels, and other glucose-metabolic parameters. Result(s): CD4+CD28null frequency was significantly higher in all PCOS groups than in control subjects. CD4+CD28null frequency was significantly higher in nonhyperandrogenic phenotype (5.7%, range 3.2-7.1) than in phenotypes with hyperandrogenism (H) + oligoamenorrhea (O) + polycystic ovary (PCO) (3.5%, range 1-5.8), H + O (3%, range 1.8-4.7), and H + PCO (2.63%, range 1.2-4.1). The relative risk of non-H phenotype for PCOS women in the highest quartile for CD4+CD28null frequency compared with PCOS women with the lowest quartile was 3.2 (95% confidence interval 1.9-5.8). Conclusion(s): Cardiovascular risk evaluation should be performed in all PCOS phenotypes. In particular, we demonstrated that the non-H phenotype has potentially increased cardiovascular risk in terms of CD4 +CD28null frequency.

Original languageEnglish
Pages (from-to)1609-1615
Number of pages7
JournalFertility and Sterility
Volume98
Issue number6
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Polycystic Ovary Syndrome
T-Lymphocytes
Phenotype
Ovary
Hyperandrogenism
C-Reactive Protein
Type 2 Diabetes Mellitus
Observational Studies
Body Mass Index
Cohort Studies
Outcome Assessment (Health Care)
Confidence Intervals
Glucose
Control Groups

Keywords

  • cardiovascular risk
  • CD4CD28
  • phenotypes
  • Polycystic ovary syndrome
  • Rotterdam criteria

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk : Relationship with polycystic ovary syndrome phenotypes. / Moro, Francesca; Morciano, Andrea; Tropea, Anna; Sagnella, Francesca; Palla, Carola; Scarinci, Elisa; Cosentino, Nicola; Niccoli, Giampaolo; Liuzzo, Giovanna; Crea, Filippo; Lanzone, Antonio; Apa, Rosanna.

In: Fertility and Sterility, Vol. 98, No. 6, 12.2012, p. 1609-1615.

Research output: Contribution to journalArticle

Moro, F, Morciano, A, Tropea, A, Sagnella, F, Palla, C, Scarinci, E, Cosentino, N, Niccoli, G, Liuzzo, G, Crea, F, Lanzone, A & Apa, R 2012, 'CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: Relationship with polycystic ovary syndrome phenotypes', Fertility and Sterility, vol. 98, no. 6, pp. 1609-1615. https://doi.org/10.1016/j.fertnstert.2012.08.015
Moro, Francesca ; Morciano, Andrea ; Tropea, Anna ; Sagnella, Francesca ; Palla, Carola ; Scarinci, Elisa ; Cosentino, Nicola ; Niccoli, Giampaolo ; Liuzzo, Giovanna ; Crea, Filippo ; Lanzone, Antonio ; Apa, Rosanna. / CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk : Relationship with polycystic ovary syndrome phenotypes. In: Fertility and Sterility. 2012 ; Vol. 98, No. 6. pp. 1609-1615.
@article{57ef3bd0b72643adab1865e748c6e94a,
title = "CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: Relationship with polycystic ovary syndrome phenotypes",
abstract = "Objective: To study the frequency of CD4+CD28null T cells, which are aggressive T lymphocytes associated with recurrent coronary instability and type 2 diabetes mellitus, in different polycystic ovary syndrome (PCOS) phenotypes and in age- and body mass index-matched healthy women. Design: Retrospective cohort observational study. Setting: Unit of human reproductive pathophysiology, university hospital. Patient(s): A total of 167 PCOS patients and 102 control subjects. Intervention(s): None. Main Outcome Measure(s): CD4+CD28null T cell frequency, high-sensitive C-reactive protein levels, and other glucose-metabolic parameters. Result(s): CD4+CD28null frequency was significantly higher in all PCOS groups than in control subjects. CD4+CD28null frequency was significantly higher in nonhyperandrogenic phenotype (5.7{\%}, range 3.2-7.1) than in phenotypes with hyperandrogenism (H) + oligoamenorrhea (O) + polycystic ovary (PCO) (3.5{\%}, range 1-5.8), H + O (3{\%}, range 1.8-4.7), and H + PCO (2.63{\%}, range 1.2-4.1). The relative risk of non-H phenotype for PCOS women in the highest quartile for CD4+CD28null frequency compared with PCOS women with the lowest quartile was 3.2 (95{\%} confidence interval 1.9-5.8). Conclusion(s): Cardiovascular risk evaluation should be performed in all PCOS phenotypes. In particular, we demonstrated that the non-H phenotype has potentially increased cardiovascular risk in terms of CD4 +CD28null frequency.",
keywords = "cardiovascular risk, CD4CD28, phenotypes, Polycystic ovary syndrome, Rotterdam criteria",
author = "Francesca Moro and Andrea Morciano and Anna Tropea and Francesca Sagnella and Carola Palla and Elisa Scarinci and Nicola Cosentino and Giampaolo Niccoli and Giovanna Liuzzo and Filippo Crea and Antonio Lanzone and Rosanna Apa",
year = "2012",
month = "12",
doi = "10.1016/j.fertnstert.2012.08.015",
language = "English",
volume = "98",
pages = "1609--1615",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk

T2 - Relationship with polycystic ovary syndrome phenotypes

AU - Moro, Francesca

AU - Morciano, Andrea

AU - Tropea, Anna

AU - Sagnella, Francesca

AU - Palla, Carola

AU - Scarinci, Elisa

AU - Cosentino, Nicola

AU - Niccoli, Giampaolo

AU - Liuzzo, Giovanna

AU - Crea, Filippo

AU - Lanzone, Antonio

AU - Apa, Rosanna

PY - 2012/12

Y1 - 2012/12

N2 - Objective: To study the frequency of CD4+CD28null T cells, which are aggressive T lymphocytes associated with recurrent coronary instability and type 2 diabetes mellitus, in different polycystic ovary syndrome (PCOS) phenotypes and in age- and body mass index-matched healthy women. Design: Retrospective cohort observational study. Setting: Unit of human reproductive pathophysiology, university hospital. Patient(s): A total of 167 PCOS patients and 102 control subjects. Intervention(s): None. Main Outcome Measure(s): CD4+CD28null T cell frequency, high-sensitive C-reactive protein levels, and other glucose-metabolic parameters. Result(s): CD4+CD28null frequency was significantly higher in all PCOS groups than in control subjects. CD4+CD28null frequency was significantly higher in nonhyperandrogenic phenotype (5.7%, range 3.2-7.1) than in phenotypes with hyperandrogenism (H) + oligoamenorrhea (O) + polycystic ovary (PCO) (3.5%, range 1-5.8), H + O (3%, range 1.8-4.7), and H + PCO (2.63%, range 1.2-4.1). The relative risk of non-H phenotype for PCOS women in the highest quartile for CD4+CD28null frequency compared with PCOS women with the lowest quartile was 3.2 (95% confidence interval 1.9-5.8). Conclusion(s): Cardiovascular risk evaluation should be performed in all PCOS phenotypes. In particular, we demonstrated that the non-H phenotype has potentially increased cardiovascular risk in terms of CD4 +CD28null frequency.

AB - Objective: To study the frequency of CD4+CD28null T cells, which are aggressive T lymphocytes associated with recurrent coronary instability and type 2 diabetes mellitus, in different polycystic ovary syndrome (PCOS) phenotypes and in age- and body mass index-matched healthy women. Design: Retrospective cohort observational study. Setting: Unit of human reproductive pathophysiology, university hospital. Patient(s): A total of 167 PCOS patients and 102 control subjects. Intervention(s): None. Main Outcome Measure(s): CD4+CD28null T cell frequency, high-sensitive C-reactive protein levels, and other glucose-metabolic parameters. Result(s): CD4+CD28null frequency was significantly higher in all PCOS groups than in control subjects. CD4+CD28null frequency was significantly higher in nonhyperandrogenic phenotype (5.7%, range 3.2-7.1) than in phenotypes with hyperandrogenism (H) + oligoamenorrhea (O) + polycystic ovary (PCO) (3.5%, range 1-5.8), H + O (3%, range 1.8-4.7), and H + PCO (2.63%, range 1.2-4.1). The relative risk of non-H phenotype for PCOS women in the highest quartile for CD4+CD28null frequency compared with PCOS women with the lowest quartile was 3.2 (95% confidence interval 1.9-5.8). Conclusion(s): Cardiovascular risk evaluation should be performed in all PCOS phenotypes. In particular, we demonstrated that the non-H phenotype has potentially increased cardiovascular risk in terms of CD4 +CD28null frequency.

KW - cardiovascular risk

KW - CD4CD28

KW - phenotypes

KW - Polycystic ovary syndrome

KW - Rotterdam criteria

UR - http://www.scopus.com/inward/record.url?scp=84870340449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870340449&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2012.08.015

DO - 10.1016/j.fertnstert.2012.08.015

M3 - Article

VL - 98

SP - 1609

EP - 1615

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -